| 1 |
Arabinogalactan-Folic Acid-Drug Conjugate for Targeted Delivery and Target-Activated Release of Anticancer Drugs to Folate Receptor-Overexpressing Cells
Pinhassi RI, Assaraf YG, Farber S, Stark M, Ickowicz D, Drori S, Domb AJ, Livney YD
Biomacromolecules, 11(1), 294, 2010 |
| 2 |
Riboflavin concentration within ABCG2-rich extracellular vesicles is a novel marker for multidrug resistance in malignant cells
Ifergan I, Goler-Baron V, Assaraf YG
Biochemical and Biophysical Research Communications, 380(1), 5, 2009 |
| 3 |
Hereditary folate malabsorption: A positively charged amino acid at position 113 of the proton-coupled folate transporter (PCFF/SLC46A1) is required for folic acid binding
Lasry I, Berman B, Glaser F, Jansen G, Assaraf YG
Biochemical and Biophysical Research Communications, 386(3), 426, 2009 |
| 4 |
Functional elements in the minimal promoter of the human proton-coupled folate transporter
Stark M, Gonen N, Assaraf YG
Biochemical and Biophysical Research Communications, 388(1), 79, 2009 |
| 5 |
PCFT/SLC46A1 promoter methylation and restoration of gene expression in human leukemia cells
Gonen N, Bram EE, Assaraf YG
Biochemical and Biophysical Research Communications, 376(4), 787, 2008 |
